A carregar...

Targeting Mutant BRAF in Melanoma: Current Status and Future Development of Combination Therapy Strategies

The discovery of activating BRAF mutations in ~50% of all melanomas has proved to be a turning point in the therapeutic management of the disseminated disease. In this commentary we review the latest research delineating the role of mutant BRAF in melanoma initiation and progression and discuss the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kudchadkar, Ragini, Paraiso, Kim H. T., Smalley, Keiran S. M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3314865/
https://ncbi.nlm.nih.gov/pubmed/22453012
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0b013e31824b436e
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!